Vaborem

meropenem/vaborbactam · Menarini Group

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vaborem, covering 2026-02-04 to 2026-03-23. Get the full timeline:

Most recent: EMA Authorised: Vaborem (meropenem trihydrate;vaborbactam) — Menarini International Operations Luxembourg S.A.